Acute Porphyria Drug Database

Monograph

A16AA04 - Mercaptamine
Not porphyrinogenic
NP

Rationale
Non-CYP metabolism.
Chemical description
Aminoacids and -derivates used in treatment of cysteinosis.

Similar drugs
Explore alternative drugs in similar therapeutic classes A16A / A16AA or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Cystagon · Cystagon, capsules 150 mg · Cystagon, capsules 50 mg · Procysbi · Procysbi 25 mg maagsapresistente capsule · Procysbi 300 mg, maagsapresistent granulaat · Procysbi 75 mg maagsapresistente capsules · Procysbi 75 mg, maagsapresistent granulaat
Belgium
Cystagon · Cystagon 150 mg gél. · Cystagon 50 mg gél. · Procysbi · Procysbi 25 mg gél. gastro-résist. · Procysbi 300 mg gran. gastro-résist. sachet · Procysbi 75 mg gél. gastro-résist. · Procysbi 75 mg gran. gastro-résist. sachet
United Kingdom
Cystagon · Cystagon 150mg capsules · Cystagon 50mg capsules · Cysteamine · Cysteamine hydrochloride powder · Procysbi · Procysbi 25mg gastro-resistant capsules · Procysbi 75mg gastro-resistant capsules
Denmark
Cystagon · Procysbi
Norway
Cystagon · Procysbi
Poland
Cystagon · Procysbi
Luxembourg
CYSTAGON · Procysbi · Procysbi 75mg
Iceland
Cystagon · Procysbi
Finland
Cystagon · PROCYSBI
Latvia
Cystagon · PROCYSBI
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙